Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 5, 2013, Pages 343-348

  Umeda, Luciana M ^a   Pereira, Andrea Z ^a   Carneiro, Glaucia ^a   Arasaki, Carlos H ^a   Zanella, Maria Teresa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; FAT MASS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; AGED; ANASTOMOSIS, ROUX-EN-Y; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84884559178     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0042     Document Type: Article

References (28)

1. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996;12:37-56.
2. Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005;111:2518-2524.
3. Ahmad J, Hameed B, Das G, et al. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects. Diabetes Res Clin Pract 2005;69:142-150
4. Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000;23:1401-1406
5. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-1888.
6. Yost TJ, Froyd KK, Jensen DR, et al. Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus. Metabolism 1995;44:786-790.
7. Saxena U, Witte LD, Goldberg IJ. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989;264:4349-4355.
8. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA. Decreased plasma lipoprotein lipase in hypoadiponectinemia: An association independent of systemic inflammation and insulin resistance. Diabetes Care 2004;27:2925-2929.
9. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
10. Geloneze B, Pereira JA, Pareja JC, et al. Overcoming metabolic syndrome in severe obesity: Adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass. Arq Bras Endocrinol Metabol 2009;53:293-300.
11. Trakhtenbroit MA, Leichman JG, Algahim MF, et al. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med 2009;122: 435-442
12. Matsubara M, Marvoka S, Katayose S. Decreased plasma adiponectin concentration in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769.
13. Ribeiro-Filho FF, Barbieri DE, Ribeiro AB, et al. Lower adiponectin levels and insulin resistance as determinant conditions of postprandial hyperlipemia. The American Diabetes Association's, 68th Scienttific Session poster 1298, 2009. New Orleans, p. A339.
14. Benedix F, Westphal S, Patschke R, et al. Weight loss and changes in salivary ghrelin and adiponectin: Comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011;21:616-624.
15. Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: Comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy - a prospective randomized trial. Surg Obes Relat Dis 2011;7: 561-568.
16. Umeda LM, Silva EA, Carneiro G, et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients. Obes Surg 2011;21:896-901.
17. Navaneethan SD, Kelly KR, Sabbagh F, et al. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 2010;20:308-315.
18. Sluiter WJ, Werkelens D, Terpstra P, et al. Glucose tolerance and insulin release, a mathematical approach II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 1976:25:245-249.
19. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
20. Isbell JM, Tamboli RA, Hansen E N, et al. The importance of caloric restriction in the early improvements in insulin sensitivityafter Roux-en-y gastric bypass surgery. Diabetes Care 2010;33:1438-1442.
21. Chai F, Wang Y, Zhou Y, et al. Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after Roux-en-y gastric bypass surgery. Obes Surg 2011;21: 768-773
22. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971.
23. -Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50: 2094-2099.
24. Sethi JK, Hotamisligil GS. The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 1999;10:19-29.
25. Poulain-Godefroy O, Froguel P. Preadipocyte response and impairment of differentiation in an inflammatory environment. Biochem Biophys Res Commun 2007;356:662-667.
26. von Eynatten M, Schneider JG, Humpert PM, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: An association independent of systemic inflammation and insulin resistance. Diabetes Care 2004;27:2925-2929.
27. Qiao L, Zou C, van der Westhuyzen DR, et al. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 2008;57:1824-1833.
28. Jabber MA, Zuhri-Yafi MI, Larrea J. Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia. J Am Coll Nutr 1998;17:458-461.